Precision Wealth Strategies, LLC Cytom X Therapeutics, Inc. Transaction History
Precision Wealth Strategies, LLC
- $267 Million
- Q3 2025
A detailed history of Precision Wealth Strategies, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Precision Wealth Strategies, LLC holds 237,081 shares of CTMX stock, worth $810,817. This represents 0.28% of its overall portfolio holdings.
Number of Shares
237,081Holding current value
$810,817% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding CTMX
# of Institutions
91Shares Held
123MCall Options Held
305KPut Options Held
121K-
Vr Adviser, LLC New York, NY14MShares$47.8 Million6.28% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$37.8 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.38MShares$32.1 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.46MShares$28.9 Million0.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.08MShares$27.6 Million0.04% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $226M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...